SCHEMBL27580997

SCHEMBL27580997

CC(C)(C)C(C)(O[SiH3])C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10925370 0.84 ALDH1A1 (0.35) TSHRALDH1A1
SCHEMBL8344987 0.81 ALDH1A1 (0.36) TSHRALDH1A1
SCHEMBL9852747 0.70 ALDH1A1 (0.32) ALDH1A1
SCHEMBL29209620 0.69 ALDH1A1 (0.35) TSHRALDH1A1CYP2D6CYP2C19HIF1A
SCHEMBL1671160 0.67 ALDH1A1 (0.44) TSHRALDH1A1CYP2D6CYP2C19HIF1A
SCHEMBL30073299 0.67 ALDH1A1 (0.44) TSHRALDH1A1CYP2D6CYP2C19HIF1A
SCHEMBL17094651 0.65 ALDH1A1 (0.36) TSHRALDH1A1
SCHEMBL23998526 0.62 GAA (0.38) TSHRALDH1A1
SCHEMBL15484348 0.61
SCHEMBL1566695 0.61 ALDH1A1 (0.45) TSHRALDH1A1CYP2D6CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101575363-B The synthetic method of Aplidine and new antitumoral derivatives and preparation and application thereof PHARMA MAR, S. A. (ES) 2016-01-27 CN disclosed
CN-104650177-A Synthetic Methods For Aplidine And New Antitumoral Derivatives, Methods Of Making And Using Them PHARMA MAR SA 2015-05-27 CN disclosed
CN-101575363-A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them PHARMA MAR SA (ES) 2009-11-11 CN disclosed
CN-1449408-A Synthetic methods for Aplidine and novel antitumor derivatives, and methods of making and using the same PHARMA MAR SA (ES) 2003-10-15 CN disclosed